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The practice of blood transfusion is very 
old and transfusion of blood was considered 
a method of restoring a person believed to 
be dying by pouring blood from another 
person into his veins. The main problems 
encountered then were clotting of blood 
and serious adverse reactions. 
Today blood transfusion therapy is 
scientific and successful. The practice of 
blood transfusion since its adventurous 
beginnings has improved dramatically. The 
decision to transfuse must be based on 
clinical judgement weighing the therapeutic 
benefits to potential risks. The possibility 
of transmitting one or more viruses to the 
recipient continues to be one of the major 
risks in transfusion mecticine. 
The prevention of infectious 
complications of blood transfusion involves 
multiple factors: 
1. Reliance on voluntary non-remunerated 
donors, donor education and selection by 
mectical criteria. Blood from remunerated 
donors poses a higher lisk of infection. 1.2 
The final quality of blood components starts 
with the selection of donors and blood 
collection. Donors should be carefully selected 
according to national regulations. In selecting 
inctividuals for blood donation the main 
purpose is to determine whether the person 
is in good health, ill unler tu prutect the 
donor against damage to Wher own health, 
and to protect the recipient against 
transmission of cliseases or drugs which could 
be detrimental to the patient. To obtain 
relevant information about the donor's 
mectical history and general health, it is 
recommended that a pre-prlnted 
questionnaire be completed. The premises 
for blood donation should be clean, well 
ventilated and with a secure water supply. 
Facilities should be available for a confidential 
interview with a donor. All the processes of 
blood donation such as preparation of 
puncture site, proper handling of containers, 
labelling etc. should be standarclised. 
2. Donation testing for infectious markers 
using increasingly sensitive screening and 
confirmation tests. Tests currently used in 
all countries of the Council of Europe detect 
HN IIII antibocties, HCV antiboclies, HBs 
Antigen and with few exceptions Treponema 
pallidum antibodies. In certain countries 
adctitional tests for hepatitis B Core 
antiboclies, ALT, and HTLV I I IT antiboclies 
are also performed. Only validated tests 
that have been licensed or authorised by 
the responsible Health Authorities are 
applied. Some of these tests are specific to 
an infection, others are only indicative. 
With the current generation of anti HIV 
I I II test kits the average window period 
is approximately 22 days. There is evidence 
that HIV I Antigen screening reduces the 
window period by approx. six days. On 
these premises the FDA issued 
recommendations for blood and plasma 
donation screening with HN I p24 antigen 
detection and a confirmatory p24 
neutralisation assay. Nucleic Acid 
amplification tests are able to detect viral 
or other microbial nucleic acid in biological 
material even when this is negative by 
'tractitional' detection techniques. Detection 
of HIV RNA by PCR shortens the HIV 
window period by approximately five days 
more than the p24 Ag testing. HCV RNA 
could be detected in plasma on average 10-
12 days after infection.3 The HBV DNA 
could not be detected until 20-30 days 
after infection.4 
The hepatitis A-E agents belong to five 
diITerent virus faml1ies. hepatitis A and E 
are mainly transmitted via the faecal-oral 
route. The hepatitis B, C and D (delta) as 
well as GBV - CN agents are 
predOminantly transmitted parentally.5,6 
In the early 90's, clusters of HA V infection 
were seen in Haemophiliacs in four European 
countries. So far there is no conclusive 
evidence that HGV causes hepatitis or any 
other disease. POSSibly it is an innocent 
bystander in cliseases caused by other agents. 
Detection ofHGV relies on the 
demonstration ofHGV specific RNA. 
Iatrogenic transmission of C JD has been 
documented for recipients of Human 
Pituitary derived hormones and dura mater 
transplants. Furthermore it was also reported 
in comeal transplants. All lookbacks in 
recipients of blood from donors who 
developed CJD were negative. 
Surrogate tests: ALT elevation precedes 
anti HCV seroconversion by about 4 weeks. 
In a small minority, hepatitis B and C 
patients may remain seronegative. An acute 
hepatitis A may be identified. Anti HBc 
may also pick up seronegative hepatitis B 
donors. Several reports have shown that 
hepatitis B Virus infection may be 
transmitted to recipients from donors with 
Anti HBc as the only serological marker of 
hepatitis B infection.1 -9 
Other viruses of potential significance 
include Parvovirus B19, HTLV I I II and 
CMV. 
In screening for infectious markers there 
must be special emphasis on training of 
staff, maintenance and calibration of 
equipment, and good documentation of 
all the steps involved. Where the donor is 
found to have a repeat reactive result on a 
first sample, a further sample should be 
tested to confirm these results and to 
confirm the identity of the donor. 
The specific approach to quality of 
screening must rely on: 
a. Internal day-to-day quality control; 
b. External QUality checks; 
c. Occasional internal exercises; 
d. External proficiency exercises. 
3. Removal of cell associated micro 
organisms by leucocyte filtration. Leucocytes 
are vectors and reservoirs for many infectious 
agents inclucting CMV and HIV. They 
may also harbour bacteria such as Yersinia 
enterocolitica. Leucocyte depleted blood is 
an acceptable alternative to CMV negative 
blood for the prevention of CMV 
transmission. Differentiated B-Iymphocytes 
appear to be responsible for transferring 
Transmissible Spongiform Encephalopathies 
to the brain, and these cells may be a vector 
of infection. Universal leucodepletion is 
today practiced in an increasing number 
of countries. 
4. All aspects of blood safety depend on 
strict adherence to good manufacturing 
procedures. All procedures must be well 
documented. The final point should be a 
comprehensive audit of all the procedures 
involved inclucting a 'Haemovigilance' 
system. Haemovigilance is oefinf'o as a 
system of surveillance, ranging from the 
collection of blooo products to the follow 
up of ff'r:ipif'nts, to gathf'r ilnrl a~~P5S 
incidents resulting from the transfusion of 
labile blood products. The aim of such a 
system is to prevent the recurrence of 
incidents by identifying their cause. 10,)) 
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Complications of Hernias: 
The most common complications of 
abdominal wall hernias are bowel 
obstruction secondary to the hernia, 
incarceration (Figure 4), and strangulation. 
These complications can often be detected 
at clinical evaluation. Presenting symptoms 
may include abdominal pain, vomiting, 
and distention. Physical examination may 
reveal a fIrm, tender abdominal wall mass. 
Abdominal distention, dehydration, or 
peritoneal signs eventually become manifest. 
After adhesions, abdominal wall hernias 
are the second leading cause of small bowel 
obstruction (10%-15% of cases). Colonic 
obstruction caused by abdominal wall 
hernia is uncommon. 
Most cases of bowel obstruction secondary 
to abdorninal wall hernia occur after 
incarceration and strangulation. In these 
cases, bowel obstruction occurs with the 
transition point at the level of the hernia. 
Key CT fmdings include (a) dilated bowel 
proximal to the hernia and (b) normal-
caliber, reduced-caliber, or collapsed bowel 
distal to the obstruction. Other fmdings 
may include tapering of the afferent and 
efferent limbs at the hernia defect, dilatation 
of the herniated bowel loops, and 
faecalization of small bowel contents 
proximal to the obstruction. Findings of 
strangulation may also be observed. 
Incarceration refers to an irreducible hernia 
and is diagnosed clinically when a hernia 
cannot be reduced or pushed back manually. 
The diagnosis of incarceration carmot be 
made with imaging alone but can be 
suggested when herniation occurs through 
Figure 6: Diffuse lumbar hernia (arrows) 
in a 58-year-old man after left 
nephrectomy for renal cell carcinoma. Note 
the extensive herniation of the mesentery 
and bowel loops through the wall defect 
a small defect and the hernia sac has a 
narrow neck (Figure 7). 
Impending strangulation of these hernias 
should be suspected when there is free fluid 
within the hernia sac, bowel wall thickening, 
or luminal dilatation (Figure 7). 
Strangulation refers to ischemia caused by 
a comprornised blood supply. It usually 
occurs when the hernia defect obstructs 
the afferent and efferent bowel loops, 
creating a closed loop within the herniated 
bowel. 
Surgical Repair 
Several different surgical procedures are 
used to repair abdominal wall hernias, ranging 
from open or laparoscopic suture repair to 
the use of mesh. To date, tension-free mesh 
repair has been accepted as the standard 
surgical technique for the majority of 
abdominal wall hernias, regardless of defect 
size, and is most commonly used. 
Figure 7: Incarcerated incisional hernia 
in a 78-year-old man. Herniation of 
stool-filled, thin-walled colon (arrow) is 
seen through a narrow abdominal wall 
defect. The patient was asymptomatic but 
presented with acute abdomen 1 month 
later. The sac of the hernia eventually 
contained extraluminal fluid and 
obstructed colon 
Occasionally tissue expanders may be 
required to help stretch the abdominal wall 
to avoid tension. Complications after surgical 
hernia repair may occur in up to 50% of 
cases, depending on surgical technique and 
the status of the hernia sac vasculature. 
Approximately one-half of these 
complications may require surgical 
reintervention. Complications include hernia 
recurrence, fluid collections, infections, small 
intestinal obstruction due to adhesions and 
mesh-related problems (such as mesh 
shrinkage due to fIbrosis) . 8J 
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